Quote | Skylight Health Group Inc Com (OTCMKTS:SHGFF)
Last: | $1.129 |
---|---|
Change Percent: | 1.71% |
Open: | $1.11 |
Close: | $1.129 |
High: | $1.13 |
Low: | $1.0976 |
Volume: | 92,595 |
Last Trade Date Time: | 05/27/2021 04:42:12 am |
News | Skylight Health Group Inc Com (OTCMKTS:SHGFF)
TORONTO, June 24, 2021 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ: SLHG; TSXV:SLHG) (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States, is pleased to announce that the Company has acquired the Doctor...
TORONTO, June 04, 2021 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (TSXV:SHG; OTCQX: SHGFF) (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States, is pleased to announce that the Company's common shares will com...
Message Board Posts | Skylight Health Group Inc Com (OTCMKTS:SHGFF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Skylight Health Group Inc Com Company Name:
SHGFF Stock Symbol:
OTCMKTS Market:
TORONTO, June 24, 2021 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ: SLHG; TSXV:SLHG) (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States, is pleased to announce that the Company has acquired the Doctor...
TORONTO, June 04, 2021 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (TSXV:SHG; OTCQX: SHGFF) (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States, is pleased to announce that the Company's common shares will com...
Skylight Health has been selected as a clinical site to enroll patients for a clinical research trial investigating ADG20, a broadly neutralizing monoclonal antibody, for use in the prevention of COVID-19 The Skylight Health Research Team will work to bring industry-sponsore...